The rate of COVID-19 associated hospitalization among children aged 5 to 11 is just 0.0008%. In real-world terms, that’s so close to zero you basically cannot lower it any further
Despite that, the U.S. Food and Drug Administration’s vaccine advisory panel — the Vaccines and Related Biological Products Advisory Committee (VRBPAC) — on June 15, 2022, unanimously approved to grant Emergency Use Authorization (EUA) to Pfizer’s and Moderna’s COVID shots for infants and young children
Pfizer’s EUA is for a three-dose regimen (3-microgram shots) for children 6 months to 5 years old; Moderna’s EUA is for a two-dose regimen (25-microgram shots) for children 6 months to 6 years
In granting this EUA, the FDA again ignored injury and death data and swept medical ethics aside
The drug companies need this last remaining age group to be included under the EUA, because once the emergency is finally declared “over,” the next phase of liability shielding requires that the shots receive approval by the CDC’s Advisory Committee on Immunization Practices (ACIP). Once the vaccine is on the childhood vaccination schedule, the vaccine makers are permanently shielded from liability for injuries and deaths that occur in any age group, including adults
"When plunder becomes a way of life for a group of men living together in society, they create for themselves, in the course of time, a legal system that authorizes it and a moral code that glorifies it."- Fredric Bastiat
During times of universal deceit, telling the truth becomes a revolutionary act.- Orwell